NICHOLS & PRATT ADVISERS LLP /MA
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1141781
BOSTON, MA
Position in TMO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$23,872,256
+$1,268,758 QoQ
Shares Held
47,615
+3.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#437
of 2,606 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 9%
Shared 91%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NICHOLS & PRATT ADVISERS LLP /MA holds $54,272,460 across 5 Diagnostics & Research names. TMO ranks #2 (44.0% of the industry book) .
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,872,256 | 47,615 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $22,603,498 | 45,986 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $24,173,494 | 41,718 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $19,574,921 | 40,359 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $11,840,242 | 29,202 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $13,813,376 | 27,760 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $12,957,888 | 24,908 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $13,995,146 | 22,625 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $11,349,219 | 20,523 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $11,094,717 | 19,089 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $9,196,467 | 17,326 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,006,527 | 9,891 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $325,572 | 624 | Shares | Other | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||